Plain-English translation of NCT07421700 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new medication called for adults with advanced bladder cancer that has spread. Some participants will receive this medication alone, while others who haven't had previous cancer treatment will receive it combined with another cancer drug called . Researchers want to learn if the medication is safe, how well it works, and how your body processes it.
Advanced bladder cancer is a serious disease, and current treatment options don't work well enough for everyone. This trial exists to find out whether this new treatment approach—either the medication by itself or combined with another drug—might help patients live longer and control their cancer better.
You likely qualify if…
You likely don't qualify if…
You will first go through a screening period to confirm you're eligible for the study. Then you'll receive the medication through an IV infusion at regular clinic visits, continuing as long as it helps your cancer and side effects remain manageable. Throughout the study, you'll have blood tests, health check-ups, and regular scans to monitor how well the treatment is working. Your doctor will also track any side effects and adjust your care as needed.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States